Consolidated Portfolio Review Corp Milestone Scientific Inc. Transaction History
Consolidated Portfolio Review Corp
- $723 Billion
- Q2 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Milestone Scientific Inc. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 14,651 shares of MLSS stock, worth $7,911. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,651
Previous 12,100
21.08%
Holding current value
$7,911
Previous $11.3 Million
17.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MLSS
# of Institutions
35Shares Held
4.61MCall Options Held
13.3KPut Options Held
500-
Vanguard Group Inc Valley Forge, PA2.18MShares$1.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA550KShares$296,8680.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX356KShares$191,9700.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2252KShares$135,9890.15% of portfolio
-
Carnegie Capital Asset Management, LLC165KShares$88,8880.0% of portfolio
About MILESTONE SCIENTIFIC INC.
- Ticker MLSS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 68,920,896
- Market Cap $37.2M
- Description
- Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that...